Category Archives: Clinical Cardiology

(UPDATED) For patients left with a persistent iatrogenic atrial septal defect (iASD) as a result of their transcatheter mitral valve procedure, taking the additional step of closing these defects does not seem to make a difference in patient recovery. Continue reading →

October 13, 2020 06:30 ET | Source: InspireMD TEL AVIV, Israel, Oct. 13, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. Continue reading →

Therapies which improve endothelial dysfunction should be considered for the treatment of patients with coronavirus disease 2019 (COVID-19) and acute coronary syndrome (ACS), according to Study results published in Clinical Research in Cardiology. Patients with angiographically confirmed ACS who tested positive (n=45) or negative (n=76) for COVID-19 and were treated across 17 hospitals in Italy, Spain, and Switzerland between February 19 and April 9 2020 were enrolled. Continue reading →

NORTHBROOK, Ill., Oct. 15, 2020 /PRNewswire/ --The winner of the American Academy of Pediatrics (AAP) 2020 Pediatric Cardiology Research Fellowship Award, funded by The Children's Heart Foundation, the nation's leading organization dedicated to funding congenital heart defect research, has been selected. Continue reading →

Randomized trials testing various anticoagulant strategies are coming, including the large US National Institutes of Health-sponsored ACTIV-4 trial, but given the recent spikes and surges in COVID-19 case numbers, many frontline doctors are still grappling with the thromboembolic risks associated with the infectious disease. That was the consensus among a group of experts gathered to kick off the TCT Connect 2020. In a session dedicated to interventional cardiology in the COVID-19 era, Sanjum Sethi, MD (NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY), highlighted the struggle many physicians face when dealing with these critically ill patients at high risk for venous thromboembolism (VTE). Continue reading →

Medtronic Also BeginsFeasibility Study of Evolut TAVR System in Moderate and Asymptomatic Aortic Stenosis Patients DUBLIN,Oct. 14, 2020 Medtronic plc announced it will begin a randomized, head-to-head study comparing two transcatheter aortic valve replacement (TAVR) systems in patients with severe symptomatic aortic stenosis (ssAS). Continue reading →

Newswise NEW YORK October 14, 2020 New data from PROSPECT ABSORB, a pilot randomized trial of percutaneous coronary intervention (PCI) of non-flow-limiting vulnerable plaques in native coronary arteries, found that PCI was safe, substantially enlarged follow-up lumen areas, and was associated with favorable long-term clinical outcomes. Findings were reported today at TCT Connect, the 32nd annual scientific symposium of the Cardiovascular Research Foundation (CRF) Continue reading →

Newswise Kansas City, Missouri & Cleveland, Ohio--The Cardiometabolic Center Alliance (CMCA), founded by Saint Lukes Mid America Heart Institute is pleased to announce the addition of University Hospitals Cleveland Medical Center as Key Strategic Partner and Charter Member. As a coalition that seeks to establish Cardiometabolic Centers of Excellence nationwide aimed at transforming the treatment of type 2 diabetes (T2D) and related cardiovascular (CV) and renal comorbidities, the CMCA considers University Hospitals (UH) a large integrated health system based in Cleveland, Ohio a key member of the Alliance. The goal of the Cardiometabolic Center Alliance is building on our existing success in Kansas City by working collaboratively with our member organizations to replicate and refine our novel clinical care delivery model, with the overarching objective of lessening the adverse impact of diabetes and its most common and morbid complications cardiovascular and kidney disease - on patients lives, said Dr. Continue reading →

(UPDATED)Patients with STEMI and COVID-19 are uniquely high risk, North American registry data show. And for patients whose door-to-balloon (D2B) times are similar to those without the viral disease, researchers say, primary PCI is preferable and feasible. COVID-19s implications for STEMI are well knownmany people experiencing heart attack symptoms have put off care during the pandemic, for example, and among patients hospitalized with the SARS-CoV-2 virus, 15% have elevated troponins, investigator Timothy Henry, MD (The Christ Hospital, Cincinnati, OH), said in a late-breaking session today during TCT Connect 2020. Continue reading →

Transthoracic echocardiography (TTE) was found to have a fair sensitivity and good specificity compared with delayed enhancement cardiac magnetic resonance (DE-CMR) for the identification of left ventricle (LV) thrombi, and computed tomography (CT) was found to have greater accuracy than transesophageal echocardiography (TEE) for detecting left atrial appendage (LAA) thrombosis, according to the results of a systematic review and meta-analysis published in Clinical Research in Cardiology. A total of 6 studies in which TTE and CMR were compared for their ability to identify LV thrombosis were analyzed, and 10 studies in which CT and TEE were compared for the detection of LAA thrombosis were examined Continue reading →